Additional file 4 of Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax

Additional file 4: Fig. S1. The detailed three CpG islands at miR-182 promoter. (A) The regions indicating the CpG islands at the miR-182 promoter. TSS: transcription start site. (B) The detailed base information of three CpG islands